399 related articles for article (PubMed ID: 26320423)
1. Hybrid Imaging in Oncology.
Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
[TBL] [Abstract][Full Text] [Related]
2. Review of functional/anatomical imaging in oncology.
Histed SN; Lindenberg ML; Mena E; Turkbey B; Choyke PL; Kurdziel KA
Nucl Med Commun; 2012 Apr; 33(4):349-61. PubMed ID: 22314804
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
5. MR/PET: a new challenge in hybrid imaging.
Werner MK; Schmidt H; Schwenzer NF
AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
[TBL] [Abstract][Full Text] [Related]
6. PET/MRI: Emerging Clinical Applications in Oncology.
Fraum TJ; Fowler KJ; McConathy J
Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
[TBL] [Abstract][Full Text] [Related]
7. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
8. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
Paul NS; Ley S; Metser U
Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
[TBL] [Abstract][Full Text] [Related]
9. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study.
Paspulati RM; Partovi S; Herrmann KA; Krishnamurthi S; Delaney CP; Nguyen NC
Abdom Imaging; 2015 Aug; 40(6):1415-25. PubMed ID: 26112492
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
12. Current Status of Hybrid PET/MRI in Oncologic Imaging.
Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R
AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894
[TBL] [Abstract][Full Text] [Related]
13. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
15. [New challenges and perspectives in nuclear medicine imaging].
Borbély K
Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
18. The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.
Chowdhury FU; Scarsbrook AF
Clin Radiol; 2008 Mar; 63(3):241-51. PubMed ID: 18275863
[TBL] [Abstract][Full Text] [Related]
19. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
20. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]